Non-invasive Diagnostic Imaging Techniques as a Window into the Diabetic Heart: A Review of Experimental and Clinical Data

G. Korosoglou; P. M. Humpert

doi:10.1055/s-2007-973083

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2007; 115(4): 211-220
DOI: 10.1055/s-2007-973083

Review

Non-invasive Diagnostic Imaging Techniques as a Window into the Diabetic Heart: A Review of Experimental and Clinical Data

G. Korosoglou¹ , P. M. Humpert²

¹Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland
²Department of Medicine 1 and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany

Abstract

Epidemiological and clinical studies show a clear association of diabetes mellitus with congestive heart failure and cardiovascular events independent of blood pressure and ischemic heart disease. The definition of ‘diabetic cardiomyopathy’ as a clinical entity, however, relies on distinct myocellular and interstitial alterations found in the myocardium of patients with diabetes. The histological findings comprise myocellular hypertrophy, thickening of capillary basement membranes, interstitial fibrosis and rarification of mitochondria on the ultrastructural level. For clinical routine, early detection of diabetic cardiomyopathy seems crucial for identification of patients at cardiovascular risk since the prevalence of heart failure in individuals with diabetes is markedly increased. Recent technical developments in cardiac magnetic resonance imaging (MRI), echocardiography as well as nuclear scintigraphy have advanced the diagnostic applications for the detection of diabetic heart disease. This review aims to present distinct aspects of diabetic cardiomyopathy that were identified using non- invasive imaging techniques. Due to the wide availability and the low costs of echocardiography, it is the most frequently used imaging technique to detect left ventricular dysfunction in patients with diabetes. MRI on the other hand can provide assessment of myocardial structure with higher spatial resolution and allows objective assessment of left ventricular function. This makes MRI an attractive alternative for the detection of discrete alterations, particularly in patients with poor echogenic windows. Finally, nuclear scintigraphy can provide information on cardiac autonomic integrity and accurately detect defects in autonomic control, which are considered a major cardiovascular risk factor in patients with diabetes.

Key words

diabetes mellitus - diabetic cardiomyopathy - non-invasive cardiac imaging - echocardiography - magnetic resonance imaging - nuclear scintigraphy

Full Text

References

1 Al-Shafei AI, Wise RG, Gresham GA, Bronns G, Carpenter TA, Hall LD. et al . Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol. 2002a; 538 541-553
2 Al-Shafei AI, Wise RG, Gresham GA, Carpenter TA, Hall LD, Huang CL. Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition. J Physiol. 2002b; 538 555-572
3 Allman KC, Stevens MJ, Wieland DM, Hutchins GD, Wolfe Jr. ER, Greene DA. et al . Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol. 1993; 22 1425-1432
4 Alvarez JA, Reyes M, Escobedo D, Freeman GL, Steinhelper ME, Feldman MD. Enhanced left ventricular systolic function early in type 2 diabetic mice: clinical implications. Diab Vasc Dis Res. 2004; 1 89-94
5 Astorri E, Fiorina P, Contini GA, Albertini D, Magnati G, Astorri A. et al . Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin Cardiol. 1997; 20 536-540
6 Attali JR, Sachs RN, Valensi P, Palsky D, Tellier P, Vulpillat M. et al . Asymptomatic diabetic cardiomyopathy: a noninvasive study. Diabetes Res Clin Pract. 1988; 4 183-190
7 Backlund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kyto V. et al . Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia. 2004; 47 325-330
8 Bajraktari G, Koltai MS, Ademaj F, Rexhepaj N, Qirko S, Ndrepepa G. et al . Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes. Int J Cardiol. 2005;
9 Baum VC, Levitsky LL, Englander RM. Abnormal cardiac function after exercise in insulin-dependent diabetic children and adolescents. Diabetes Care. 1987; 10 319-323
10 Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care. 2003; 26 2433-2441
11 Bertoni AG, Goff Jr. DC, D'Agostino Jr. RB, Liu K, Hundley WG, Lima JA. et al . Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2006; 29 588-594
12 Bidasee KR, Zhang Y, Shao CH, Wang M, Patel KP, Dincer UD. et al . Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca²⁺-ATPase. Diabetes. 2004; 53 463-473
13 Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J. et al . Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 2001; 50 2792-2808
14 Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI. et al . Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. Jama. 1993; 270 1702-1707
15 Bohler S, Glaesmer H, Pittrow D, Lehnert H, Stalla GK, Zeiher AM. et al . Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues - rationale for a nationwide primary care project in Germany. Exp Clin Endocrinol Diabetes. 2004; 112 157-170
16 Bourassa MG, Gurne O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M. et al . Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol. 1993; 22 14A-19A
17 Boyer JK, Thanigaraj S, Schechtman KB, Perez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004; 93 870-875
18 Carlstrom S, Karlefors T. Haemodynamic studies on newly diagnosed diabetics before and after adequate insulin treatment. Br Heart J. 1970; 32 355-358
19 Chatham JC, Forder JR. Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am J Physiol. 1997; 273 H52-8
20 Chen V, Ianuzzo CD, Fong BC, Spitzer JJ. The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes. 1984; 33 1078-1084
21 Chung J, Abraszewski P, Yu X, Liu W, Krainik AJ, Ashford M. et al . Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. J Am Coll Cardiol. 2006; 47 384-390
22 Daoud S, Schinzel R, Neumann A, Loske C, Fraccarollo D, Diez C. et al . Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts. Mol Med. 2001; 7 543-551
23 DeMaria AN, Wisenbaugh TW, Smith MD, Harrison MR, Berk MR. Doppler echocardiographic evaluation of diastolic dysfunction. Circulation. 1991; 84 I288-95
24 Dent CL, Bowman AW, Scott MJ, Allen JS, Lisauskas JB, Janif M. et al . Echocardiographic characterization of fundamental mechanisms of abnormal diastolic filling in diabetic rats with a parameterized diastolic filling formalism. J Am Soc Echocardiogr. 2001; 14 1166-1172
25 Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ. et al . Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol. 2003; 42 328-335
26 Dirksen MS, Bax JJ, de Roos A, Jukema JW, van der Geest RJ, Geleijns K. et al . Usefulness of dynamic multislice computed tomography of left ventricular function in unstable angina pectoris and comparison with echocardiography. Am J Cardiol. 2002; 90 1157-1160
27 Dumesnil JG, Gaudreault G, Honos GN, Kingma Jr JG. Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol. 1991; 68 515-519
28 Edvardsen T, Gerber BL, Garot J, Bluemke DA, Lima JA, Smiseth OA. Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation. 2002; 106 50-56
29 Factor SM, Bhan R, Minase T, Wolinsky H, Sonnenblick EH. Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease. Am J Pathol. 1981; 102 219-228
30 Factor SM, Minase T, Sonnenblick EH. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J. 1980; 99 446-458
31 Fang ZY, Leano R, Marwick TH. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond). 2004a; 106 53-60
32 Fang ZY, Najos-Valencia O, Leano R, Marwick TH. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol. 2003; 42 446-453
33 Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004b; 25 543-567
34 Fava S, Azzopardi J, Muscat HA, Fenech FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care. 1993; 16 1615-1618
35 Fischer SE, McKinnon GC, Maier SE, Boesiger P. Improved myocardial tagging contrast. Magn Reson Med. 1993; 30 191-200
36 Fonseca CG, Dissanayake AM, Doughty RN, Whalley GA, Gamble GD, Cowan BR. et al . Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction. Am J Cardiol. 2004; 94 1391-1395
37 Friedman NE, Levitsky LL, Edidin DV, Vitullo DA, Lacina SJ, Chiemmongkoltip P. Echocardiographic evidence for impaired myocardial performance in children with type I diabetes mellitus. Am J Med. 1982; 73 846-850
38 Ganguly PK, Thliveris JA, Mehta A. Evidence against the involvement of nonenzymatic glycosylation in diabetic cardiomyopathy. Metabolism. 1990; 39 769-773
39 Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 1998; 32 865-875
40 Garvey WT, Hardin D, Juhaszova M, Dominguez JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol. 1993; 264 H837-44
41 Giacomelli F, Wiener J. Primary myocardial disease in the diabetic mouse. An ultrastructural study. Lab Invest. 1979; 40 460-473
42 Gotzsche O, Darwish A, Gotzsche L, Hansen LP, Sorensen KE. Incipient cardiomyopathy in young insulin-dependent diabetic patients: a seven-year prospective Doppler echocardiographic study. Diabet Med. 1996; 13 834-840
43 Grandi AM, Piantanida E, Franzetti I, Bernasconi M, Maresca A, Marnini P. et al . Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus. Am J Cardiol. 2006; 97 71-76
44 Hartmann F, Ziegler S, Nekolla S, Hadamitzky M, Seyfarth M, Richardt G. et al . Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart. 1999; 81 262-270
45 Hayashi K, Okumura K, Matsui H, Murase K, Kamiya H, Saburi Y. et al . Involvement of 1,2-diacylglycerol in improvement of heart function by etomoxir in diabetic rats. Life Sci. 2001; 68 1515-1526
46 Hoit BD, Castro C, Bultron G, Knight S, Matlib MA. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail. 1999; 5 324-333
47 Hsu KL, Chiang FT, Lo HM, Tsai CH, Tseng CD, Tseng YZ. Cardiac contractility in noninsulin dependent diabetes mellitus evaluated using the relation between endsystolic wall stress and velocity of circumferential fiber shortening. Jpn Heart J. 1997; 38 463-471
48 Hutchins GD, Chen T, Carlson KA, Fain RL, Winkle W, Vavrek T. et al . PET imaging of oxidative metabolism abnormalities in sympathetically denervated canine myocardium. J Nucl Med. 1999; 40 846-853
49 Jackson CV, McGrath GM, Tahiliani AG, Vadlamudi RV, McNeill JH. A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy. Diabetes. 1985; 34 876-883
50 Joffe II, Travers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan JP. et al . Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol. 1999; 34 2111-2119
51 Juergens KU, Grude M, Maintz D, Fallenberg EM, Wichter T, Heindel W. et al . Multi-detector row CT of left ventricular function with dedicated analysis software versus MR imaging: initial experience. Radiology. 2004; 230 403-410
52 Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979; 2 120-126
53 Karvounis HI, Papadopoulos CE, Zaglavara TA, Nouskas IG, Gemitzis KD, Parharidis GE. et al . Evidence of left ventricular dysfunction in asymptomatic elderly patients with non-insulin-dependent diabetes mellitus. Angiology. 2004; 55 549-555
54 Kawaguchi M, Techigawara M, Ishihata T, Asakura T, Saito F, Maehara K. et al . A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels. 1997; 12 267-274
55 Korosoglou G, Humpert PM, Halbgewachs E, Bierhaus A, Katus H, Nawroth PP. et al . Evidence of Left Ventricular Contractile Asynchrony in Asymptomatic Patients with Type II Diabetes. AJ Cardiol. 2006; 98 1525-1530
56 Kosmala W, Kucharski W, Przewlocka-Kosmala M, Mazurek W. Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am J Cardiol. 2004; 94 395-399
57 Kozak-Barany A, Jokinen E, Kero P, Tuominen J, Ronnemaa T, Valimaki I. Impaired left ventricular diastolic function in newborn infants of mothers with pregestational or gestational diabetes with good glycemic control. Early Hum Dev. 2004; 77 13-22
58 Lainchbury JG, Redfield MM. Doppler echocardiographic-guided diagnosis and therapy of heart failure. Curr Cardiol Rep. 1999; 1 55-66
59 Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res. 1988; 62 535-542
60 Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes. 2003; 111 215-222
61 Loganathan R, Bilgen M, Al-Hafez B, Smirnova IV. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging. 2006; 22 81-90
62 Mahnken AH, Koos R, Katoh M, Spuentrup E, Busch P, Wildberger JE. et al . Sixteen-slice spiral CT versus MR imaging for the assessment of left ventricular function in acute myocardial infarction. Eur Radiol. 2005; 15 714-720
63 Mahnken AH, Spuentrup E, Niethammer M, Buecker A, Boese J, Wildberger JE. et al . Quantitative and qualitative assessment of left ventricular volume with ECG-gated multislice spiral CT: value of different image reconstruction algorithms in comparison to MRI. Acta Radiol. 2003; 44 604-611
64 Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A. et al . Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995; 26 57-65
65 Mantysaari M, Kuikka J, Mustonen J, Tahvanainen K, Vanninen E, Lansimies E. et al . Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes. 1992; 41 1069-1075
66 Mantysaari M, Kuikka J, Mustonen J, Tahvanainen K, Vanninen E, Lansimies E. et al . Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus. Clin Auton Res. 1996; 6 163-169
67 Marantz PR, Tobin JN, Wassertheil-Smoller S, Steingart RM, Wexler JP, Budner N. et al . The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation. 1988; 77 607-612
68 Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003; 26 1895-1901
69 Matsumoto Y, Kaneko M, Kobayashi A, Fujise Y, Yamazaki N. Creatine kinase kinetics in diabetic cardiomyopathy. Am J Physiol. 1995; 268 E1070-6
70 Matsumura Y, Elliott PM, Virdee MS, Sorajja P, Doi Y, McKenna WJ. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart. 2002; 87 247-251
71 Mbanya JC, Sobngwi E, Mbanya DS, Ngu KB. Left ventricular mass and systolic function in African diabetic patients: association with microalbuminuria. Diabetes Metab. 2001; 27 378-382
72 McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J. et al . Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation. 1999; 100 1056-1064
73 Metzler B, Schocke MF, Steinboeck P, Wolf C, Judmaier W, Lechleitner M. et al . Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson. 2002; 4 493-502
74 Miyanaga H, Yoneyama S, Kamitani T, Kawasaki S, Takahashi T, Kunishige H. Clinical usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction. Jpn Circ J. 1995; 59 599-607
75 Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N. et al . Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 2000; 101 899-907
76 Murata K, Sumida Y, Murashima S, Matsumura K, Takeda H, Nakagawa T. et al . A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Diabet Med. 1996; 13 266-272
77 Nagamachi S, Jinnouchi S, Nakahara H, Flores 2nd LG, Ohnishi T, Hoshi H. et al . 123I-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy. Nucl Med Commun. 1996; 17 621-632
78 Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001; 24 1614-1619
79 Nugent AM, Steele IC, al-Modaris F, Vallely S, Moore A, Campbell NP. et al . Exercise responses in patients with IDDM. Diabetes Care. 1997; 20 1814-1821
80 Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001; 24 5-10
81 Pop-Busui R, Kirkwood I, Schmid H, Marinescu V, Schroeder J, Larkin D. et al . Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol. 2004; 44 2368-2374
82 Raggi P. Role of electron-beam computed tomography and nuclear stress testing in cardiovascular risk assessment. Am J Cardiol. 2005; 96 20J-27J
83 Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med. 1993; 10 820-824
84 Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR. et al . Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. 1977; 60 884-899
85 Riordan MM, Chung CS, Kovacs SJ. Diabetes and diastolic function: stiffness and relaxation from transmitral flow. Ultrasound Med Biol. 2005; 31 1589-1596
86 Riordan MM, Kovacs SJ. Quantitation of mitral annular oscillations and longitudinal “ringing” of the left ventricle: a new window into longitudinal diastolic function. J Appl Physiol. 2006; 100 112-119
87 Robillon JF, Sadoul JL, Jullien D, Morand P, Freychet P. Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration. Diabete Metab. 1994; 20 473-480
88 Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972; 30 595-602
89 Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995; 92 2157-2162
90 Salazar J, Rivas A, Rodriguez M, Felipe J, Garcia MD, Bone J. Left ventricular function determined by Doppler echocardiography in adolescents with type I (insulin-dependent) diabetes mellitus. Acta Cardiol. 1994; 49 435-439
91 Saraiva RM, Duarte DM, Duarte MP, Martins AF, Poltronieri AV, Ferreira ME. et al . Tissue Doppler imaging identifies asymptomatic normotensive diabetics with diastolic dysfunction and reduced exercise tolerance. Echocardiography. 2005; 22 561-570
92 Schaible TF, Malhotra A, Bauman WA, Scheuer J. Left ventricular function after chronic insulin treatment in diabetic and normal rats. J Mol Cell Cardiol. 1983; 15 445-458
93 Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 2002; 98 33-39
94 Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P. et al . Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation. 2003; 107 3040-3046
95 Schmid H, Forman LA, Cao X, Sherman PS, Stevens MJ. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes. 1999; 48 603-608
96 Schnell O, Kirsch CM, Stemplinger J, Haslbeck M, Standl E. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia. 1995; 38 1345-1352
97 Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes. 1996; 45 801-805
98 Schuijf JD, Bax JJ, Jukema JW, Lamb HJ, Vliegen HW, Salm LP. et al . Noninvasive angiography and assessment of left ventricular function using multislice computed tomography in patients with type 2 diabetes. Diabetes Care. 2004; 27 2905-2910
99 Semeniuk LM, Kryski AJ, Severson DL. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol. 2002; 283 H976-82
100 Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH. et al . Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997; 30 474-480
101 SOLVD-Investigators . Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991; 325 293-302
102 Stevens MJ, Dayanikli F, Raffel DM, Allman KC, Sandford T, Feldman EL. et al . Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol. 1998a; 31 1575-1584
103 Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T. et al . Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation. 1998b; 98 961-968
104 Struthers AD, Morris AD. Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet. 2002; 359 1430-1432
105 Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J. et al . Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J. 2000; 21 1368-1375
106 Suys BE, Katier N, Rooman RP, Matthys D, Op De Beeck L, Du Caju MV. et al . Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care. 2004; 27 1947-1953
107 Taskiran M, Rasmussen V, Rasmussen B, Fritz-Hansen T, Larsson HB, Jensen GB. et al . Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy. Diabet Med. 2004; 21 524-530
108 Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes. 2002; 51 1166-1171
109 Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MI. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Diabetes Care. 1996; 19 1083-1090
110 Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003; 26 1553-1579
111 Von Bibra H, Thrainsdottir IS, Hansen A, Dounis V, Malmberg K, Ryden L. Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res. 2005; 2 24-30
112 von Bibra H, Tuchnitz A, Klein A, Schneider-Eicke J, Schomig A, Schwaiger M. Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacologic stress testing: a comparison with stress echocardiography and perfusion scintigraphy. J Am Coll Cardiol. 2000; 36 444-452
113 Witteles RM, Tang WH, Jamali AH, Chu JW, Reaven GM, Fowler MB. Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link. J Am Coll Cardiol. 2004; 44 78-81
114 Zanzonico P, Rothenberg LN, Strauss HW. Radiation exposure of computed tomography and direct intracoronary angiography: risk has its reward. J Am Coll Cardiol. 2006; 47 1846-1849
115 Ziegler D, Weise F, Langen KJ, Piolot R, Boy C, Hubinger A. et al . Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia. 1998; 41 443-451

Correspondence

Dr.med. P. M. Humpert

Universitätsklinikum Heidelberg

Medizinische Klinik 1 und Klinische Chemie

Im Neuenheimer Feld 410

69120 Heidelberg

Phone: +49/6221/56 80 27

Fax: +49/6221/56 42 33

Email: per.humpert@med.uni-heidelberg.de